By Rudy A. Mazzocchi
We’ve all been impacted by movies like Blood Diamond (the 2006 political thriller written by Charles Leavitt) which revealed the atrocities of the diamond industry and exposed the exploitation of humanity for the sake of profit and personal gain. There are many unfortunate examples of such inhumanities, the worst of which includes both biblical and modern slavery.
EQUITY of EVIL exposes similar atrocities associated with the illicit black market of human organ trafficking. It outlines a twisted scheme by a wealthy foreign syndicate to manipulate key people and companies in order to monopolize this growing multi-billion dollar market. Rather than compete with limited legitimate sources that are supported by governments, institutions, or foundations that solicit organ donations, or illegal means that include ‘assassinations for organs’, extraction of organs from living or deceased prisoners, or ‘cash for organs’ in the black market, this powerful syndicate funds the harvesting and growing of human organs from aborted fetuses.
Based on true events, EQUITY of EVIL captures the science and medical procedures capable of supporting this business thesis, and includes real-life characters that are manipulated or influenced by their own personal greed or self-interest. Protagonists in the story eventually learn that they are but pawns in a global chess-game, slaves to faceless masters, who attempt to right their wrongs. The Antagonists are blinded by their empathy and greed, unmoved by their atrocities to their fellow man, simply focused on the ‘brass ring’ and their ultimate goals. The clash between the two provide a rollercoaster ride for the reader, as they explore and experience various perspectives that may cause them to consider their own political, ethical and moral viewpoints.
As an author of such a novel, my goal was to simply reveal some of the exciting, but often scary, new medical innovations that are on the horizon—new innovations that will surely force us to think about how we are going to deal with new political and ethical issues as a global society. I also hope that readers will relate to many of the main characters, many of whom attempt to do the right things for the right reasons. As in our own lives, many of us stumble and recover, being stronger for the experience, while others lose themselves and barely survive.
I intend to maintain such a theme in a trilogy called “The EQUITY Series” in which other bold new technologies are brought to light only to be exploited by evil individuals and/or companies for the sake of profit. Stay tuned!
Rudy A. Mazzocchiis best known as a medical device and biotechnology entrepreneur, inventor, and angel investor, with a history of starting new technology ventures throughout the U.S. and Europe. He’s been privileged to have the opportunity to see the newest innovations in healthcare and work with some of the most brilliant researchers, scientists and physicians in the industry.
Authoring more than 50 patents, he has helped pioneer new companies involved in cardiology, oncology, orthopedics, neurosurgery and even embryonic stem-cell development. Through these efforts, he has become the recipient of many technology and business awards, including the Ernst & Young Entrepreneur of the Year in Healthcare and the Businessman of the Year Award.
Combining these experiences and opportunities, with thousands of hours of travel and long evenings in hotel rooms, he found the initiative to start writing a collection of medical thrillers based on true events, the first of which is entitled EQUITY of EVIL.
You can visit his website at www.rudymazzocchi.com.
Book Trailer: http://www.youtube.com/watch?v=KAYkQEQBnLk